我国药品投诉举报制度影响因素的实证研究  

Empirical study on the influential factors of the drug complaint and reporting system in China

作　　者：梁云 王广平[1] 邵蓉[1] LIANG Yun;WANG Guangping;SHAO Rong(Research Center of National Drug Policy&Ecosystem,China Pharmaceutical University,Nanjing 211198,China)

机构地区：[1]中国药科大学国家药物政策与医药产业经济研究中心,南京211198

出　　处：《中国药房》2022年第4期385-390,共6页China Pharmacy

基　　金：国家社会科学基金重大项目(No.15ZDB167);中国药科大学“双一流”学科创新团队建设项目(No.CPU2018GY39)。

摘　　要：目的为完善我国药品投诉举报制度、提高药品安全社会共治水平提供借鉴。方法以广东省为例,采用文献回顾、问卷调查、结构方程模型(SEM)等方法,对"互联网+"途径、药品质量、药品专业知识、投诉举报程序、投诉举报方式、投诉举报动机、政府奖励和行政复议或诉讼等药品投诉举报制度影响因素进行分析。结果与结论共收到3375份问卷,均为有效问卷;绝大多数受访者居住地为广东。药品投诉举报制度影响因素的实证分析结果显示,"互联网+"途径与药品专业知识、投诉举报程序和投诉举报方式的路径系数均大于0.9,提示"互联网+"推进了公众药品投诉举报方式和行为的转变。建议我国在药品投诉举报制度的设计中,不仅要吸引社会公众参与到投诉举报处理中来,而且要利用互联网的发展来培养社会公众的治理能力,规范职业打假行为,推进"数字政府"机构改革,适当调整药品监管机构的工作职责,进而减少我国药品投诉举报数量,优化药品安全治理体系。OBJECTIVE To improve the drug complaint and reporting system in China,and to provide reference for improving the social multi-component governance level of the drug safety.METHODS Taking Guangdong province as an example,literature review,questionnaire survey,structural equation model and other methods were used to analyze influential factors of the drug complaint and reporting system,such as“Internet+”approach,drug quality,specialized drug knowledge,complaint and reporting procedures,complaint and reporting methods,complaint and reporting motivation,governmental reward,administrative review or litigation.RESULTS&CONCLUSIONS A total of 3375 questionnaires were received,all of which were valid;the vast majority of respondents lived in Guangdong province.The results of the empirical analysis of the influential factors of drug complaint and reporting system showed that the path coefficients of“Internet+”approach and specialized drug knowledge,complaint and reporting procedures,complaint and reporting methods were all greater than 0.9,indicating“Internet+”promoted the transformation of the way and behavior of complaint and reporting.It is suggested that the design of the drug complaint and reporting system should not only attract the public to participate in drug complaint and reporting,but also cultivate the public’s management capacity through the approach of internet,standardize professional anti-counterfeiting behavior,promote the institutional reform of“digital government”,and appropriately adjust the work responsibilities of drug regulatory department,so as to reduce the number of drug complaint and reporting in China,and optimize the drug safety governance system.

关 键 词：药品 投诉举报制度 广东省 实证研究 问卷调查 结构方程模型 

分 类 号：R95[医药卫生—药学]